To this end, we analyzed the gene expression dataset GSE3007042, and found that the levels of microRNA predicted by the online software TARGETSCAN for CHK1 were significantly different between cancer and control samples (Supplementary Fig. 4B). This evidence concerns the gene CHEK1 and cancer.